Enlivex Therapeutics Ltd. (ENLV.TA)

ILA 337.5

(2.09%)

Long Term Debt Summary of Enlivex Therapeutics Ltd.

  • Enlivex Therapeutics Ltd.'s latest annual long term debt in 2023 was 686 Thousand USD , down -83.64% from previous year.
  • Enlivex Therapeutics Ltd.'s latest quarterly long term debt in 2024 Q2 was 499 Thousand USD , down 0.0% from previous quarter.
  • Enlivex Therapeutics Ltd. reported annual long term debt of 4.19 Million USD in 2022, down -22.17% from previous year.
  • Enlivex Therapeutics Ltd. reported annual long term debt of 5.38 Million USD in 2021, up 1079859.92% from previous year.
  • Enlivex Therapeutics Ltd. reported quarterly long term debt of 587 Thousand USD for 2024 Q1, down 0.0% from previous quarter.
  • Enlivex Therapeutics Ltd. reported quarterly long term debt of 686 Thousand USD for 2023 FY, down -83.64% from previous quarter.

Annual Long Term Debt Chart of Enlivex Therapeutics Ltd. (2023 - 2012)

Historical Annual Long Term Debt of Enlivex Therapeutics Ltd. (2023 - 2012)

Year Long Term Debt Long Term Debt Growth
2023 686 Thousand USD -83.64%
2022 4.19 Million USD -22.17%
2021 5.38 Million USD 1079859.92%
2020 499.00 USD 67.45%
2019 298.00 USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%

Peer Long Term Debt Comparison of Enlivex Therapeutics Ltd.

Name Long Term Debt Long Term Debt Difference
Matricelf Ltd - ILA -Infinity%